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Summary
To move closer to understanding the mechanistic under-
pinnings of sex differences in human longevity, we stud-
ied pet dogs to determine whether lifetime duration of
ovary exposure was associated with exceptional longev-
ity. This hypothesis was tested by collecting and analyz-
ing lifetime medical histories, age at death, and cause of
death for a cohort of canine ‘centenarians’ – exception-
ally long-lived Rottweiler dogs that lived more than
30% longer than average life expectancy for the breed.
Sex and lifetime ovary exposure in the oldest-old Rot-
tweilers (age at death, ‡ 13 years) were compared to a
cohort of Rottweilers that had usual longevity (age at
death, 8.0–10.8 years). Like women, female dogs were
more likely than males to achieve exceptional longevity
(OR, 95% CI = 2.0, 1.2–3.3; P = 0.006). However, removal
of ovaries during the ﬁrst 4 years of life erased the
female survival advantage. In females, a strong positive
association between ovaries and longevity persisted in
multivariate analysis that considered other factors, such
as height, body weight, and mother with exceptional
longevity. A beneﬁcial effect of ovaries on longevity in
females could not be attributed to resistance against a
particular disease or major cause of death. Our results
document in dogs a female sex advantage for achieving
exceptional longevity and show that lifetime ovary
exposure, a factor not previously evaluated in women,
is associated with exceptional longevity. This work
introduces a conceptual framework for designing addi-
tional studies in pet dogs to deﬁne the ovary-sensitive
biological processes that promote healthy human lon-
gevity.
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Female survival advantage is well documented in certain
mammalian species, most notably humans (Austad, 2006).
This translates into a greater likelihood that women will live
to 100 years, outnumbering men by approximately 4:1
(Terry et al., 2008). Little progress, however, has been made
to elucidate the mechanisms of sex differences in human
longevity. Transplantation of mouse ovaries from young
donors into ovariectomized female mice increased life
expectancy proportional to age of the recipient (Cargill
et al., 2003). But the mouse, biogerontology’s most trusted
mammalian workhorse, is not likely the most trustworthy
mimic of the sex differences in human longevity, because
female mice are typically outlived by their male counterparts
(Turturro et al., 2002; Austad, 2006).
Whether ovary removal early in life can re-set longevity
parameters in humans has not been evaluated, as few young
women undergo ovariectomy. In contrast, a large percentage of
pet dogs undergo elective ovariectomy at different ages
throughout the life course, creating a research opportunity to
study the dose–response between endogenous ovarian function
and longevity. Here, by studying pet dogs living in the same
environment as humans (Waters & Wildasin, 2006), we test
the hypothesis that lifetime ovary exposure is signiﬁcantly asso-
ciated with exceptional longevity.
A database was established to construct lifetime medical his-
tories for a cohort of 119 oldest-old Rottweiler dogs living in
North America. These pet dogs lived with their owners and
females underwent elective ovariectomy at different ages
throughout the life course. Information on medical history, age
at death and cause of death was collected by questionnaire and
telephone interviews with pet owners and veterinarians as previ-
ously reported (Cooley et al., 2003). Rottweilers with excep-
tional longevity lived ‡ 13 years, i.e. more than 30% longer
than average life expectancy for the breed (9.4 years). In each
case, date of birth obtained from American Kennel Club regis-
tration records was used to validate exceptional longevity. Sex
(female:male) and lifetime duration of ovary exposure in the
oldest-old dogs were compared with information collected
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lTable 1 Characteristics of female Rottweilers in study population
Usual longevity
1
N = 100 dogs
Exceptional longevity
2
N = 83 dogs
Age at death
3 (years), median (IQR) 9.6 (9.0–10.0) 13.6 (13.3–14.3)
Year of birth (range) 1984–2000 1980–1995
Residence
Geographic distribution 29 states, Canada 27 states, Canada
Number of households
4 93 79
Lifetime ovary exposure
5 (years), median (IQR) 2.5 (0.7–6.0) 5.5 (2.0–7.5)
Reproductive history
6
Nulliparity in dogs with intact ovaries for ‡ 12 months (%) 26 ⁄ 62 (42) 24 ⁄ 70 (34)
Body weight
7 (lbs), median (IQR) 90.0 (85.0–100.0) 85.0 (79.2–90.0)
Height
8 (in), median (IQR) 24.0 (23.0–24.5) 23.5 (22.6–24)
Mother achieved exceptional longevity, n (%)
9
Yes 1 (3) 11 (22)
No 30 (97) 40 (78)
Cause of death
10, n (%)
Cancer – all types 73 (73) 25 (32)
Bone sarcoma
11 38 (38) 6 (8)
Other types 35 (35) 19 (24)
Non-cancer diseases
12 27 (27) 53 (68)
Gastrointestinal 8 (8) 4 (5)
Musculoskeletal 6 (6) 8 (10)
Cardiovascular 4 (4) 3 (4)
Neurologic 2 (2) 7 (9)
Urologic 1 (1) 2 (3)
Frailty
13 1 (1) 16 (21)
Other
14 3 (3) 7 (9)
Unknown 2 (2) 6 (8)
IQR = interquartile range, which indicates the difference between the 1st and 3rd quartiles.
1Usual longevity cohort represents dogs that died at 8.0–10.8 years, a range surrounding the breed-speciﬁc median age at death established in a population-
based study of more than 700 Rottweilers (Cooley et al., 2003). The 100 females in the usual longevity group include 34 dogs previously reported by Cooley
et al. The female:male ratio in the usual longevity cohort was 100:86 (1.26:1). Median (range) age at death for usual longevity males was 9.5 (8.0–10.7 years).
2Exceptional longevity cohort represents dogs that died at ‡ 13.0 years, which is more than 30% longer than the breed-speciﬁc median longevity (9.4 years).
The 83 females in the exceptional longevity group include nine exceptionally long-lived dogs reported by Cooley et al. (2003). The female:male ratio in the
exceptional longevity cohort was 83:36 (2.30:1). Median (range) age at death for exceptional longevity males was 13.6 (13.0–15.5 years).
3For each dog, age at death was validated using date of birth from American Kennel Club registration records or medical records. The vast majority (> 80%)
of dogs underwent elective euthanasia when their quality of life was considered unacceptable by owner.
4The 183 female dogs in the study population resided in 172 different households. Only 18 owners had more than one dog represented in the study
population. Eleven owners had one dog in the usual longevity cohort and one dog in the exceptional longevity cohort.
5For each dog, duration of ovary exposure is equivalent to age at ovariectomy established in the medical history provided by owners and veterinarians.
6Thirty-eight usual longevity dogs and 13 exceptional longevity dogs underwent early ovariectomy prior to breeding age, i.e. ovariectomy during ﬁrst
12 months of life. These dogs were not eligible for reproduction. After excluding these dogs, the table shows a similar percentage of dogs from both
groups were not exposed to the ‘reproductive cost’ of offspring.
7Body weight was obtained from owner questionnaire or medical record, representing when the dog was a healthy 5 to 7-year-old adult.
8For each dog, height represents shoulder height, the distance measured from ground to shoulder, reported by owner.
9Data reported here represents only those cases in which information on the longevity of the mother could be validated directly from the owner of the
mother. Validated data were available for mothers of 82 of the 183 index females in the study population. A more detailed analysis of the apparent familial
clustering of exceptional longevity in these dogs is in progress.
10For each dog, cause of death was determined by reviewing medical records and medical histories provided by veterinarians and owners. Few causes of
death were veriﬁed by necropsy and therefore the reliability of these data is likely comparable to that of human mortality studies based on death
certiﬁcates. There is no reason to suspect that the cause of death was preferentially misclassiﬁed in dogs with usual longevity vs. dogs with exceptional
longevity, or misclassiﬁed on the basis of ovarian hormone exposure as classiﬁcation of cause of death was made by investigators (DJW, AHM) blinded to
age at ovariectomy. In eight of 183 dogs (two usual longevity, six exceptional longevity), cause of death could not be ascertained from the clinical data.
11Bone cancer (appendicular bone sarcoma) was diagnosed based upon physical examination and radiographs. In some cases, histologic conﬁrmation was
made by pathologic examination of tissues obtained at biopsy or necropsy.
12Death caused by non-cancer diseases was subdivided into ﬁve major categories on the basis of frequency: gastrointestinal (e.g. intestinal perforation;
inﬂammatory bowel disease); musculoskeletal (e.g. severe arthritis); cardiovascular (e.g. congestive heart failure); neurologic (e.g. compressive myelopathy
due to intervertebral disk herniation; seizures); and urologic (e.g. chronic renal failure).
13Death was attributed to frailty in those dogs whose owners and veterinarians reported death or euthanasia associated with a combination of age-related
disabilities, including deﬁcits in mobility, cognition, hearing, eyesight and inability to maintain body weight.
14Dogs in this category included those whose cause of death was attributed to less common conditions: hematologic, endocrine, hepatobiliary, or respiratory
diseases; environmental causes (e.g. heat stroke); and dogs that died in their sleep without recognized illness.
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753from another cohort of 186 Rottweilers in the same catchment
area that had usual longevity (age at death 8.0–10.8 years).
Like women, female dogs were more likely than males to
achieve exceptional longevity (OR, 95% CI = 2.0, 1.2–3.3;
P = 0.006). However, removal of ovaries during the ﬁrst 4 years
of life (i.e. median age at ovariectomy) erased the female
survival advantage over males (OR, 95% CI = 1.2, 0.7–2.2;
P = 0.55). In females that retained their ovaries for more than
4 years, likelihood of exceptional longevity increased to more
than three times that of males (OR, 95% CI = 3.2, 1.8–5.7;
P < 0.0001).
To further deﬁne the dose–response relationship between
ovaries and longevity, we focused our analysis on the 83 excep-
tional longevity females and 100 usual longevity females
(Table 1). This enabled us to address the following question: Is
the duration of ovary exposure during the ﬁrst 8 years of life
associated with an increased likelihood of achieving exceptional
longevity? When females from the exceptional longevity and
usual longevity cohorts were combined then subdivided into
tertiles based upon ovary exposure during the ﬁrst 8 years of
life, dogs with the longest ovary exposure (6.1–8.0 years) were
3.2 times more likely to reach exceptional longevity than dogs
with shortest exposure (P = 0.002) (Table 2; Supporting
Fig. S1). In multivariate analysis, the association between
increasing ovary exposure and exceptional longevity remained
strong even after considering other factors that might inﬂuence
longevity, such as height, body weight and whether mother
achieved exceptional longevity (Table 2).
Finally, we evaluated whether the survival advantage in
females with intact ovaries could be explained by a protective
effect of ovaries against a particular disease. In Rottweilers with
usual longevity, the major cause of death and major death cate-
gory were bone sarcoma and cancer-all types, accounting for
38% and 73% deaths, respectively. We found that, after
excluding bone cancer deaths or all cancer deaths, the strong
association between intact ovaries and exceptional longevity
persisted. After excluding all cancer deaths, females who kept
their ovaries during the ﬁrst 7 years of life (i.e. highest tertile of
ovary exposure) were more than nine times more likely to reach
exceptional longevity than females with shortest ovary exposure
(P = 0.001) (Table 2).
Our results show that in Rottweiler dogs, like in humans, there
is a strong female sex advantage for reaching exceptional lon-
gevity. Importantly, the longevity advantage over males is abol-
ished in females that undergo early or mid-life ovarian removal.
To our knowledge, this is the ﬁrst demonstration that lifetime
ovary exposure is signiﬁcantly associated with exceptional lon-
gevity in any mammalian species.
By studying dogs that underwent elective ovariectomy at
different ages, we were able to probe the dose–response rela-
tionship between endogenous ovarian function and exceptional
longevity. A possible longevity-promoting effect of ovaries in
exceptionally long-lived dogs in this study is supported by data
from another cohort of pet dogs that we have investigated (Sup-
porting Fig. S2). In a population of 237 female Rottweiler dogs
who died at 1.3–12.9 years, females that had intact ovaries for
the ﬁrst 4.5 years of life had 37% lower mortality than females
that underwent elective ovariectomy before 4.5 years, i.e.,
median age at ovariectomy (hazard ratio, 95% CI = 0.63,
0.49–0.82; P < 0.0001 log-rank test). The research strategy
advanced here by our group – using a national population of
registered, pure-bred dogs of a single breed, carefully quantitat-
ing the duration of ovary exposure rather than binning dogs into
a category of either ‘intact’ or ‘ovariectomized’ – lessens the
likelihood of misclassiﬁcation bias that likely plagued previous
dog studies (Bronson, 1982; Michell, 1999).
Recognizing that observed associations between exposures
and outcomes may not necessarily be causal, we explored
alternative, non-causal explanations for the association
between ovaries and exceptional longevity. But, we found no
evidence that factors which may inﬂuence a pet owner’s deci-
Table 2 Endogenous ovary exposure and likelihood of exceptional longevity
in female Rottweiler dogs
All females
Duration of ovary exposure during the ﬁrst
8 years of life (tertiles)
1
shortest
23
longest
Univariate
Odds ratio
1 (95% CI) 1.0 1.6 (0.8–3.4) 3.2 (1.6–6.7)
Range of ovary
exposure (years)
0.4–2.0 2.1–6.0 6.1–8.0
Number of dogs 65 57 61
Multivariate
2
Odds ratio (95% CI) 1.0 2.4 (0.8–7.2) 4.6 (1.3–16.2)
Range of ovary
exposure (years)
0.4–2.0 2.1–6.0 6.1–8.0
Number of dogs 28 28 26
Bone cancer excluded
3
Odds ratio (95% CI) 1.0 2.5 (1.1–5.8) 3.9 (1.6–9.3)
Range of ovary
exposure (years)
0.4–2.4 2.5–6.5 6.6–8.0
Number of dogs 45 45 44
All cancer excluded
4
Odds ratio (95% CI) 1.0 4.0 (1.3–12.2) 9.7 (2.3–40.7)
Range of ovary
exposure (years)
0.4–3.1 3.2–7.0 7.1–8.0
Number of dogs 27 30 23
1Odds ratios were considered signiﬁcant if 95% conﬁdence interval did not
include 1.0.
2Multivariate odds ratio for 82 females adjusted for height, adult body
weight, and mother reaching exceptional longevity. In stepwise regression,
in addition to duration of ovary exposure, a second variable, mother
reaching exceptional longevity (OR, 95% CI = 8.3, 1.0–67.4), was selected
suggesting a strong familial clustering of long-lived individuals.
3For this analysis, the 44 female dogs whose cause of death was bone
cancer were excluded. Appendicular bone sarcoma was the most
frequently reported cause of mortality in Rottweilers with usual longevity
(8.0–10.8 years).
4For this analysis, 98 female dogs whose cause of death was cancer of any
type were excluded. The odds ratios indicate duration of ovary exposure is
signiﬁcantly associated with exceptional longevity in dogs that succumb to
non-cancer causes.
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754sion on age at ovariectomy – for example, earlier ovariectomy
in dogs with substandard conformation or delayed ovariec-
tomy to obtain more offspring in daughters of long-lived
mothers – can adequately account for the strong association
(Supporting Appendix S1). Further, our results mirror the
recent ﬁndings from more than 29 000 women in the Nurses’
Health Study (Parker et al., 2009). In that study, women who
had elective hysterectomy with ovary sparing had lower overall
mortality than those who underwent hysterectomy with ovari-
ectomy. Notably, the beneﬁt of keeping ovaries experienced
by women under 50 years was attributable to decreased car-
diovascular and cancer mortality (Parker et al., 2009). Taken
together, the ﬁndings from dogs and women support the
hypothesis that early life physiological inﬂuences, such as ovar-
ian hormones, lay the foundation for adult health outcomes
including longevity. Further testing of the ovary-longevity
hypothesis should utilize experimental designs that capture the
broad range of lifetime ovary exposure seen in the pet dog
population so that the critical windows of ovary exposure can
be better deﬁned.
Speciﬁc mechanisms have been proposed by which ovaries
might promote longevity, including estrogen-induced
enhanced immune response (Austad, 2006; Straub, 2007) and
protection against oxidative stress (Borras et al., 2003). We
could not attribute the ovary-associated longevity advantage in
dogs to resistance against a particular disease. Instead, we
observed a robust ovarian association with longevity that was
independent of cause of death, suggesting that a network of
processes regulating the intrinsic rate of aging is under ovarian
control. Future studies in dogs and women are warranted to
deﬁne speciﬁc ovarian longevity factors and to identify ovary-
sensitive biological processes that promote healthy longevity.
Pet dogs should provide a tractable mammalian model to
investigate the mechanisms of how ovaries orchestrate
extended longevity in both species.
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Additional supporting information may be found in the online
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Fig. S1 Life course analysis of ovary exposure during the ﬁrst
8 years of life in dogs with usual longevity vs. exceptional lon-
gevity.
Fig. S2 Increased lifetime ovary exposure is associated with
increased longevity in 237 female Rottweiler dogs.
Appendix S1 Additional analysis used to explore alternative,
non-causal explanations for the association between lifetime
ovary exposure and exceptional longevity.
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